Testing effectiveness (Phase 2)Active Not RecruitingNCT06569823
What this trial is testing
Safety and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adults 50 Years of Age and Over
Who this might be right for
ShinglesHerpes ZosterVaccine-Preventable Diseases
Dynavax Technologies Corporation 764